Your search returned 30 studies:
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Johnson Creek, Wisconsin
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Johnson Creek, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Summit, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Oconomowoc, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Summit, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Beloit, Wisconsin
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Conditions: Prostate Cancer
Location: Oconomowoc, Wisconsin
- Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Summit, Wisconsin
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Summit, Wisconsin
- A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Conditions: Prostate Neoplasms
Location: Madison, Wisconsin
- Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer - Stage I Prostate Cancer - Stage IIA Prostate Cancer - Stage IIB Prostate Cancer - Stage III Prostate Cancer
Location: Oconomowoc, Wisconsin
- Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- A Multicenter Clinical Study of the Sonablate®500 for the Treatment of Locally Recurrent Prostate Cancer With HIFU
Conditions: Recurrent Prostate Cancer
Location: Madison, Wisconsin
- Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer - Castration Resistant Prostate Cancer - Pain - Prostatic Neoplasms
Location: Madison, Wisconsin
- Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Conditions: Solid Malignancies - Metastatic Castrate-resistant Prostate Cancer
Location: Madison, Wisconsin
- Study of 124I-NM404 in Advanced Solid Malignancies
Conditions: Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer
Location: Madison, Wisconsin
- Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Madison, Wisconsin
- Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Br
Conditions: Castration-resistant Prostate Cancer, - Metastatic Breast Cancer - Uterine Leiomyoma
Location: Madison, Wisconsin
- Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Conditions: Hot Flashes in Men With Prostate Cancer Receiving Androgen Ablation Therapy
Location: Madison, Wisconsin
- Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- A Phase 2 Diagnostic Imaging Study With 99mTc-MIP-1404 in Men With High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pel
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- Sodium Flouride (NaF) Positron Emission Tomograpy/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) W
Conditions: Prostate Cancer
Location: Madison, Wisconsin
- NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant
Conditions: Prostatic Neoplasms - Prostate Cancer
Location: Madison, Wisconsin
|